ARGX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
ARGX is a good buy right now for a beginner-focused, long-term investor with $50,000-$100,000 to deploy. The stock has strong fundamental growth, a favorable analyst backdrop, and no negative insider or political selling signals. While the short-term chart is not strongly bullish, the long-term business momentum and recent Q1 beat on EPS support buying now rather than waiting.
The trend is mixed to slightly weak in the very short term. MACD histogram is -2.23 and still negatively expanding, which shows near-term momentum is soft. RSI_6 is 45.38, neutral and not oversold. Moving averages are converging, suggesting the stock is consolidating rather than trending decisively. Price closed near 787.12, just below the pivot of 794.54, with support at 761.75 and resistance at 827.32. Overall, the chart does not show a strong breakout, but it is also not technically broken for long-term accumulation.
Q1 results were strong operationally: revenue rose 64.16% YoY to $1.298B, net income increased 115.97% YoY to $366M, EPS rose 113.95% YoY to 5.52, and gross margin improved to 90.68%. News also highlights $4.9B in cash and equivalents, supporting continued R&D and expansion. Analyst sentiment remains constructive, with multiple Buy/Outperform ratings and several firms calling current levels attractive. Goldman added ARGX to its European Conviction List, and Wells Fargo still sees major upside over the next 12-24 months.
The latest quarter revenue of $1.3B missed the $1.31B consensus despite the EPS beat, which may explain the short-term pressure. Technical momentum is currently weak, with a negative MACD histogram and the stock trading slightly below the pivot. Recent analyst price targets were trimmed by Stifel and Oppenheimer, showing some moderation in expectations. The stock trend model also suggests mild weakness over the next month.
Latest quarter: Q1 2026. Revenue increased to $1.298B, up 64.16% YoY. Net income increased to $366M, up 115.97% YoY. EPS increased to 5.52, up 113.95% YoY. Gross margin reached 90.68%, up 1.00% YoY. This is a very strong growth quarter overall, especially for a long-term investor.
Analyst sentiment is positive overall, with a clear pros-bias on Wall Street. Stifel kept Buy and raised its target to $1,222 from $1,227 after the in-line Q1 report, saying consensus revenue looks beatable. Oppenheimer kept Outperform but lowered its target to $1,014. Goldman added the stock to its European Conviction List. Deutsche Bank upgraded to Buy, and Wells Fargo remains Overweight with a $1,247 target. The main con view is that a few targets were trimmed after Q4/Q1 modeling updates, but the broader Street stance remains bullish.
